Medicare Expands Staff, Expertise to Enforce Drug Price Program

The US Medicare agency is moving forward with implementation of its drug price negotiation program by bringing in more staff, meeting with manufacturers, and listening to patient voices, a top CMS official said.

Meena Seshamani, director of the agency’s Center for Medicare, discussed where the agency stands with its drug price negotiation program during a Tuesday conversation at the Milken Institute’s 2023 Future of Health Summit.

“We have made it a priority to really engage with everyone who’s interested and impacted by this historic work,” Seshamani said. That includes regular meetings with patients, providers, health plans, and drug manufacturers, as ...